These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1354 related articles for article (PubMed ID: 8604398)

  • 1. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New aspects in histogenesis of hyperplasia and cancers of the prostate].
    Bonkhoff H; Remberger K
    Verh Dtsch Ges Pathol; 1993; 77():31-9. PubMed ID: 7511302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status.
    Bonkhoff H
    Prostate Suppl; 1998; 8():18-22. PubMed ID: 9690659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem/progenitor and intermediate cell types and the origin of human prostate cancer.
    Tokar EJ; Ancrile BB; Cunha GR; Webber MM
    Differentiation; 2005 Dec; 73(9-10):463-73. PubMed ID: 16351690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prostate cancer cultures are models for androgen-independent transit amplifying cells.
    Bühler P; Wolf P; Katzenwadel A; Schultze-Seemann W; Wetterauer U; Freudenberg N; Elsässer-Beile U
    Oncol Rep; 2010 Feb; 23(2):465-70. PubMed ID: 20043108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
    Landry F; Chapdelaine A; Bégin LR; Chevalier S
    J Urol; 1996 Jan; 155(1):386-90. PubMed ID: 7490893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell kinetics of prostate exocrine and neuroendocrine epithelium and their differential interrelationship: new perspectives.
    Xue Y; Smedts F; Verhofstad A; Debruyne F; de la Rosette J; Schalken J
    Prostate Suppl; 1998; 8():62-73. PubMed ID: 9690665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging of the prostate epithelial stem/progenitor cell.
    Zenzmaier C; Untergasser G; Berger P
    Exp Gerontol; 2008 Nov; 43(11):981-5. PubMed ID: 18639623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal architecture of human prostatic epithelium in benign and malignant conditions.
    Gaisa NT; Graham TA; McDonald SA; Poulsom R; Heidenreich A; Jakse G; Knuechel R; Wright NA
    J Pathol; 2011 Oct; 225(2):172-80. PubMed ID: 21898875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
    Bonkhoff H; Stein U; Aumüller G; Remberger K
    Prostate; 1996 Oct; 29(4):261-7. PubMed ID: 8876709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.
    Alberti C
    G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate cells in normal and malignant prostate epithelium express c-MET: implications for prostate cancer invasion.
    van Leenders G; van Balken B; Aalders T; Hulsbergen-van de Kaa C; Ruiter D; Schalken J
    Prostate; 2002 May; 51(2):98-107. PubMed ID: 11948964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer.
    Verhagen AP; Ramaekers FC; Aalders TW; Schaafsma HE; Debruyne FM; Schalken JA
    Cancer Res; 1992 Nov; 52(22):6182-7. PubMed ID: 1384957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cell cultures as models of prostate cancer development.
    Peehl DM
    Endocr Relat Cancer; 2005 Mar; 12(1):19-47. PubMed ID: 15788637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
    Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
    Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphogenesis of benign prostatic hyperplasia and prostatic carcinoma].
    Bonkhoff H; Remberger K
    Pathologe; 1998 Jan; 19(1):12-20. PubMed ID: 9541938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.